Self-made double-lumen jejunal tube for bile reinfusion and enteral nutrition after percutaneous transhepatic cholangial drainage

Table 1 Baseline characteristics of study patients, mean ± SD/n (%)

Characteristic	Observation group (n = 60)	Control group (n = 60)	Test statistic	P value
Demographics
Age (years)	58.2 ± 6.5	58.9 ± 7.0	t = 0.40	0.693
Gender (male/female)	34/26	32/28	χ2 = 0.07	0.795
BMI (kg/m2)	23.5 ± 3.0	23.2 ± 2.8	t = 0.42	0.678
Baseline nutritional status
Serum albumin (g/L)	32.1 ± 3.2	31.8 ± 3.5	t = 0.35	0.731
Prealbumin (mg/L)	180 ± 25	178 ± 28	t = 0.30	0.767
Transferrin (mg/L)	2.0 ± 0.3	1.9 ± 0.4	t = 0.98	0.332
Liver function tests
Total bilirubin (μmol/L)	280 ± 50	275 ± 45	t = 0.42	0.674
Direct bilirubin (μmol/L)	180 ± 30	175 ± 35	t = 0.62	0.539
ALT (U/L)	120 ± 20	118 ± 22	t = 0.38	0.703
AST (U/L)	110 ± 18	108 ± 20	t = 0.42	0.677
Disease etiology
Benign biliary disease	30 (50.0)	28 (46.7)	χ2 = 0.07	0.796
Malignant biliary disease	30 (50.0)	32 (53.3)	χ2 = 0.07	0.796
Comorbidities
Hypertension	20 (33.3)	22 (36.7)	χ2 = 0.07	0.786
Diabetes mellitus	16 (26.7)	14 (23.3)	χ2 = 0.09	0.766
Chronic kidney disease	6 (10.0)	4 (6.7)	Fisher’s	1.000

BMI: Body mass index; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase.